Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for IBS and GAD
NCT00961298Phase 4Completed
- Sponsor
- Allegheny Health Network
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of duloxetine in irritable bowel syndrome (IBS), generalized anxiety disorder (GAD), sponsored by Allegheny Health Network. Started Sep 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
irritable bowel syndrome (IBS)generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00961298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961298.